A detailed history of First City Capital Management, Inc. transactions in Bio Techne Corp stock. As of the latest transaction made, First City Capital Management, Inc. holds 2,950 shares of TECH stock, worth $223,905. This represents 0.12% of its overall portfolio holdings.

Number of Shares
2,950
Previous 3,185 7.38%
Holding current value
$223,905
Previous $224,000 5.8%
% of portfolio
0.12%
Previous 0.13%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$62.12 - $84.15 $14,598 - $19,775
-235 Reduced 7.38%
2,950 $211,000
Q1 2024

May 22, 2024

BUY
$65.98 - $77.09 $12,206 - $14,261
185 Added 6.17%
3,185 $224,000
Q4 2023

Feb 07, 2024

SELL
$52.83 - $78.22 $5,283 - $7,822
-100 Reduced 3.23%
3,000 $231,000
Q4 2022

Feb 13, 2023

BUY
$80.67 - $352.29 $187,557 - $819,074
2,325 Added 300.0%
3,100 $256,000
Q2 2022

Jul 21, 2022

SELL
$322.67 - $449.65 $11,293 - $15,737
-35 Reduced 4.32%
775 $269,000
Q4 2021

Feb 07, 2022

SELL
$456.15 - $525.06 $15,965 - $18,377
-35 Reduced 4.14%
810 $332,000
Q3 2021

Oct 28, 2021

SELL
$444.87 - $538.88 $22,243 - $26,944
-50 Reduced 5.59%
845 $409,000
Q1 2021

May 13, 2021

SELL
$314.62 - $411.0 $34,608 - $45,210
-110 Reduced 10.95%
895 $366,000
Q4 2020

Feb 12, 2021

SELL
$246.9 - $321.87 $187,644 - $244,621
-760 Reduced 43.06%
1,005 $397,000
Q3 2020

Nov 16, 2020

BUY
$232.22 - $282.96 $123,076 - $149,968
530 Added 42.91%
1,765 $437,000
Q2 2020

Aug 14, 2020

BUY
$185.43 - $279.56 $229,006 - $345,256
1,235 New
1,235 $326,000

Others Institutions Holding TECH

About BIO-TECHNE Corp


  • Ticker TECH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,222,600
  • Market Cap $2.98B
  • Description
  • Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...
More about TECH
Track This Portfolio

Track First City Capital Management, Inc. Portfolio

Follow First City Capital Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First City Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on First City Capital Management, Inc. with notifications on news.